Items where authors include "Hoskin, P"

Article

Zhong, J orcid.org/0000-0001-5325-3739, Frood, R, McWilliam, A et al. (11 more authors) (2023) Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings. La Radiologia Medica, 128. pp. 765-774. ISSN 0033-8362

Zhong, J orcid.org/0000-0001-5325-3739, Brown, S orcid.org/0000-0002-7975-7537, Serra, M et al. (17 more authors) (2022) Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT). BMJ Open, 12 (11). e068580. ISSN 2044-6055

Andratschke, N, Willmann, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Parker, CC, James, ND, Brawley, CD et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Henry, A orcid.org/0000-0002-5379-6618, Pieters, BR, André Siebert, F et al. (2 more authors) (2022) GEC-ESTRO ACROP prostate brachytherapy guidelines. Radiotherapy and Oncology, 167. pp. 244-251. ISSN 0167-8140

Thomson, DJ, Yom, SS, Saeed, H et al. (20 more authors) (2020) Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development. International Journal of Radiation: Oncology - Biology - Physics, 108 (2). pp. 379-389. ISSN 0360-3016

Witjes, JA, Babjuk, M, Bellmunt, J et al. (119 more authors) (2020) Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]. European Urology, 78 (1). e48-e50. ISSN 0302-2838

Salembier, C, Henry, A orcid.org/0000-0002-5379-6618, Pieters, BR et al. (1 more author) (2020) A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial. Journal of Contemporary Brachytherapy, 12 (1). pp. 1-5. ISSN 1689-832X

Witjes, JA, Babjuk, M, Bellmunt, J et al. (118 more authors) (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology, 77 (2). pp. 223-250. ISSN 0302-2838

Horwich, A, Babjuk, M, Bellmunt, J et al. (118 more authors) (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology, 30 (11). pp. 1697-1727. ISSN 0923-7534

Mohammed, W, Hoskin, P, Henry, A orcid.org/0000-0002-5379-6618 et al. (3 more authors) (2018) Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease. Clinical Oncology, 30 (9). pp. 534-538. ISSN 0936-6555

Salembier, C, Villeirs, G, De Bari, B et al. (2 more authors) (2018) ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiotherapy and Oncology, 127 (1). pp. 49-61. ISSN 0167-8140

Binzel, K, Adelaja, A, Wright, CL et al. (202 more authors) (2018) Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018. EJNMMI Research, 8 (Suppl 1). 5. ISSN 2191-219X

Murray, L orcid.org/0000-0003-0658-6455, Mason, J, Henry, AM orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology, 120 (2). pp. 293-299. ISSN 0167-8140

Kane, CM, Hoskin, P and Bennett, MI (2015) Cancer induced bone pain. BMJ, 350. ISSN 0959-8138

Murray, L orcid.org/0000-0003-0658-6455, Henry, A orcid.org/0000-0002-5379-6618, Hoskin, P et al. (2 more authors) (2014) Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique. Radiotherapy and Oncology, 110 (2). pp. 213-228. ISSN 0167-8140

Murray, L orcid.org/0000-0003-0658-6455, Henry, A orcid.org/0000-0002-5379-6618, Hoskin, P et al. (2 more authors) (2013) Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiation Oncology, 8. 172. ISSN 1748-717X

Conference or Workshop Item

Datta, A, Forker, L, McWilliam, A et al. (10 more authors) (2021) Association of radiomic features with aggressive phenotypes in soft tissue sarcomas. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain.

Zhong, J, Slevin, F, Scarsbrook, A orcid.org/0000-0002-4243-032X et al. (5 more authors) (2021) Systematic Review of Salvage Reirradiation Options for Locally Recurrent Prostate Cancer. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain & Online.

Proceedings Paper

Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X, Teoh, EJ et al. (11 more authors) (2019) Impact of Positron Emission Tomography (PET) with 18F-Fluciclovine on Management of Patients with Recurrence of Prostate Cancer: Results from the Falcon Trial. In: Proceedings of the Amercian Society for Radiation Oncology 61st Annual Meeting. The Amercian Society for Radiation Oncology 61st Annual Meeting, 15-18 Sep 2019, Chicago, IL, USA. Elsevier , S136-S137.

Teoh, E, Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X et al. (15 more authors) (2017) Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial. In: International Journal of Radiation Oncology Biology Physics. 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), 24-27 Sep 2017, San Diego, CA, USA. Elsevier , pp. 1316-1317.